US 10125369
PCSK9 iRNA compositions and methods of use thereof
granted A61KA61K31/713A61K47/549
Quick answer
US patent 10125369 (PCSK9 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 85
- CPC classes
- A61K, A61K31/713, A61K47/549, A61P, A61P3/06